Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Oxytetracycline 250mg tablets
0501030T0AAAJAJ
|
Oxytetracycline (Systemic) | Oxytetracycline | Infections | 43,023 |
|
Oxymycin 250mg tablets
0501030T0BFAAAJ
|
Oxymycin | Oxytetracycline | Infections | No data available |
|
Oxytetracycline 100mg/5ml oral suspension
0501030T0AAATAT
|
Oxytetracycline (Systemic) | Oxytetracycline | Infections | No data available |
|
Oxytetracycline 125mg/5ml oral suspension
0501030T0AAAPAP
|
Oxytetracycline (Systemic) | Oxytetracycline | Infections | No data available |
|
Oxytetracycline 250mg/5ml oral suspension
0501030T0AAAQAQ
|
Oxytetracycline (Systemic) | Oxytetracycline | Infections | No data available |
|
Oxytetracycline 500mg/5ml oral suspension
0501030T0AAARAR
|
Oxytetracycline (Systemic) | Oxytetracycline | Infections | No data available |
|
Oxytetramix 250 tablets
0501030T0BIAAAJ
|
Oxytetramix-250 | Oxytetracycline | Infections | No data available |
|
Terramycin 250mg tablets
0501030T0BGABAJ
|
Terramycin (Systemic) | Oxytetracycline | Infections | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.